In the News
Discover the latest developments, scientific advancements, and partnerships shaping the future of healthcare at CAGE Bio.
Latest CAGE Bio Updates
CAGE Bio Advances Skin Disease Treatment
Ionic liquid formulation delivers chemotherapy to tumors
CAGE Bio Advances Skin Disease Treatment
Samir Mitragotri, PhD, a professor of bioengineering at Harvard University and founder of CAGE Bio, has developed innovative approaches to address challenges in dermatological medicine. His research explores ionic liquid-based therapeutics, aiming to enhance drug delivery directly into the skin. This localized approach seeks to improve tr
Samir Mitragotri, PhD, a professor of bioengineering at Harvard University and founder of CAGE Bio, has developed innovative approaches to address challenges in dermatological medicine. His research explores ionic liquid-based therapeutics, aiming to enhance drug delivery directly into the skin. This localized approach seeks to improve treatment efficacy for skin conditions while potentially reducing systemic adverse events.
Novel Hand Sanitizer to Fight COVID-19
Ionic liquid formulation delivers chemotherapy to tumors
CAGE Bio Advances Skin Disease Treatment
Ionic liquid formulation delivers chemotherapy to tumors
Ionic liquid formulation delivers chemotherapy to tumors
Ionic liquid formulation delivers chemotherapy to tumors
Welcome! Check out our latest news.
CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis